Vaccination against cholera in Juba – Authors' reply

Iza Ciglenecki, Andrew Azman, John Rumunu, Jean Clement Cabrol, Francisco J. Luquero

Research output: Contribution to journalLetter

Original languageEnglish (US)
Pages (from-to)480-481
Number of pages2
JournalThe Lancet Infectious Diseases
Volume17
Issue number5
DOIs
StatePublished - May 1 2017

Fingerprint

Cholera
Vaccination

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

Vaccination against cholera in Juba – Authors' reply. / Ciglenecki, Iza; Azman, Andrew; Rumunu, John; Cabrol, Jean Clement; Luquero, Francisco J.

In: The Lancet Infectious Diseases, Vol. 17, No. 5, 01.05.2017, p. 480-481.

Research output: Contribution to journalLetter

Ciglenecki, Iza ; Azman, Andrew ; Rumunu, John ; Cabrol, Jean Clement ; Luquero, Francisco J. / Vaccination against cholera in Juba – Authors' reply. In: The Lancet Infectious Diseases. 2017 ; Vol. 17, No. 5. pp. 480-481.
@article{6af73331e0e84d408a8c77a8fad99406,
title = "Vaccination against cholera in Juba – Authors' reply",
author = "Iza Ciglenecki and Andrew Azman and John Rumunu and Cabrol, {Jean Clement} and Luquero, {Francisco J.}",
year = "2017",
month = "5",
day = "1",
doi = "10.1016/S1473-3099(17)30184-6",
language = "English (US)",
volume = "17",
pages = "480--481",
journal = "The Lancet Infectious Diseases",
issn = "1473-3099",
publisher = "Lancet Publishing Group",
number = "5",

}

TY - JOUR

T1 - Vaccination against cholera in Juba – Authors' reply

AU - Ciglenecki, Iza

AU - Azman, Andrew

AU - Rumunu, John

AU - Cabrol, Jean Clement

AU - Luquero, Francisco J.

PY - 2017/5/1

Y1 - 2017/5/1

UR - http://www.scopus.com/inward/record.url?scp=85018635784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018635784&partnerID=8YFLogxK

U2 - 10.1016/S1473-3099(17)30184-6

DO - 10.1016/S1473-3099(17)30184-6

M3 - Letter

C2 - 28447952

AN - SCOPUS:85018635784

VL - 17

SP - 480

EP - 481

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

SN - 1473-3099

IS - 5

ER -